These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6798767)

  • 21. Glucuronidation of haloperidol by rat liver microsomes: involvement of family 2 UDP-glucuronosyltransferases.
    Narayanan R; LeDuc B; Williams DA
    Life Sci; 2004 Apr; 74(20):2527-39. PubMed ID: 15010263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of UDP-glucuronyltransferase activity in rat liver microsomes by pyrimidine derivatives.
    Naydenova Z; Grancharov K; Shopova M; Golovinsky E
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Nov; 112(3):321-5. PubMed ID: 8838685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substrate specificity and properties of uridine diphosphate glucuronyltransferase purified to apparent homogeneity from phenobarbital-treated rat liver.
    Burchell B
    Biochem J; 1978 Sep; 173(3):749-57. PubMed ID: 101208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the zebrafish Ugt repertoire reveals a new class of drug-metabolizing UDP glucuronosyltransferases.
    Wang Y; Huang H; Wu Q
    Mol Pharmacol; 2014 Jul; 86(1):62-75. PubMed ID: 24728488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigations on the kinetic properties of estrone glucuronyltransferase from pig kidney.
    Rao ML; Rao GS; Breuer H
    Biochim Biophys Acta; 1976 Nov; 452(1):89-100. PubMed ID: 10996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of increased amounts of UDP-glucuronyltransferase protein in phenobarbital-treated chick-embryo liver cells.
    Burchell B; Pratt GJ; Duffy I; West L
    Biochem J; 1983 Aug; 214(2):517-23. PubMed ID: 6412703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of UDP-glucuronyltransferase activities in human liver microsomes.
    Bock KW; Lilienblum W; von Bahr C
    Drug Metab Dispos; 1984; 12(1):93-7. PubMed ID: 6141920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of glucuronosyltransferase activity in the human cancer cell line LNCaP, evidence for the presence of at least two glucuronosyltransferase enzymes.
    Guillemette C; Hum DW; Bélanger A
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):355-62. PubMed ID: 8541232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
    Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
    Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective function of a microsomal UDP-glucuronyltransferase in Gunn rats.
    Nakata D; Zakim D; Vessey DA
    Proc Natl Acad Sci U S A; 1976 Feb; 73(2):289-92. PubMed ID: 813224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inducibility and ontogeny of rat liver UDP-glucuronyltransferase toward furosemide.
    Rachmel A; Hazelton GA
    Biochem Pharmacol; 1986 Nov; 35(21):3777-82. PubMed ID: 3096336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic properties of the rat intestinal microsomal 1-naphthol:UDP-glucuronosyl transferase. Inhibition by UDP and UDP-N-acetylglucosamine.
    Koster AS; Noordhoek J
    Biochim Biophys Acta; 1983 Nov; 761(1):76-85. PubMed ID: 6416300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes.
    Soars MG; Petullo DM; Eckstein JA; Kasper SC; Wrighton SA
    Drug Metab Dispos; 2004 Jan; 32(1):140-8. PubMed ID: 14709631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of multiple activities of UDP-glucuronyltransferase in human liver.
    Leakey JE; Hume R; Burchell B
    Biochem J; 1987 May; 243(3):859-61. PubMed ID: 3117034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential inhibition by diazepam and nitrazepam of UDP-glucuronyltransferase activities in rats.
    del Villar E; Sanchez E; Letelier ME; Vega P
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):433-47. PubMed ID: 6800002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation.
    Senafi SB; Clarke DJ; Burchell B
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):233-40. PubMed ID: 7945246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of microsomal UDP-glucuronyltransferase in needle-biopsy specimens of human liver.
    Bock KW; Brunner G; Hoensch H; Huber E; Josting D
    Eur J Clin Pharmacol; 1978 Dec; 14(5):367-73. PubMed ID: 103726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid and non-steroid UDP glucuronyltransferase: glucuronidation of synthetic estrogens as steroids.
    Lucier GW; McDaniel OS
    J Steroid Biochem; 1977 Aug; 8(8):867-72. PubMed ID: 413009
    [No Abstract]   [Full Text] [Related]  

  • 39. UDP-glucuronic acid binds first and the aglycone substrate binds second to form a ternary complex in UGT1A9-catalyzed reactions, in both the presence and absence of bovine serum albumin.
    Manevski N; Yli-Kauhaluoma J; Finel M
    Drug Metab Dispos; 2012 Nov; 40(11):2192-203. PubMed ID: 22912433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of troglitazone on glucuronidation catalyzed by human uridine diphosphate-glucuronosyltransferase 1A6.
    Ito M; Yamamoto K; Sato H; Fujiyama Y; Bamba T
    Eur J Clin Pharmacol; 2001 Mar; 56(12):893-5. PubMed ID: 11317477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.